Cargando…

IL-6–HaloTag(®) enables live-cell plasma membrane staining, flow cytometry, functional expression, and de-orphaning of recombinant odorant receptors

The assignment of cognate odorant/agonist pairs is a prerequisite for an understanding of odorant coding at the receptor level. However, the identification of new ligands for odorant receptors (ORs) in cell-based assays has been challenging, due to their individual and rather sub-optimal plasma memb...

Descripción completa

Detalles Bibliográficos
Autores principales: Noe, Franziska, Frey, Tim, Fiedler, Julia, Geithe, Christiane, Nowak, Bettina, Krautwurst, Dietmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Biological Methods 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706138/
https://www.ncbi.nlm.nih.gov/pubmed/31453235
http://dx.doi.org/10.14440/jbm.2017.206
Descripción
Sumario:The assignment of cognate odorant/agonist pairs is a prerequisite for an understanding of odorant coding at the receptor level. However, the identification of new ligands for odorant receptors (ORs) in cell-based assays has been challenging, due to their individual and rather sub-optimal plasma membrane expression, as compared with other G protein-coupled receptors. Accessory proteins, such as the chaperone RTP1S, or Ric8b, have improved the surface expression of at least a portion of ORs. Typically, recombinant ORs carry N-terminal tags, which proved helpful for their functional membrane expression. The most common tag is the ‘Rho-tag’, representing an N-terminal part of rhodopsin, but also ‘Lucy-’ or ‘Flag-tag’ extensions have been described. Here, we used a bi-functional N-terminal tag, called ‘interleukin 6 (IL-6)-HaloTag(®)’, with IL-6 facilitating functional cell surface expression of recombinant ORs, and the HaloTag(®) protein, serving as a highly specific acceptor for cell-impermeant or cell-permeant, fluorophore-coupled ligands, which enable the quantification of odorant receptor expression by live-cell flow cytometry. Our experiments revealed on average an about four-fold increased surface expression, a four-fold higher signaling amplitude, and a significantly higher potency of odorant-induced cAMP signaling of six different human IL-6-HaloTag(®)-ORs across five different receptor families in NxG 108CC15 cells, as compared to their Rho-tag–HaloTag(®) constructs. We observed similar results in HEK-293 cells. Moreover, screening an IL-6–HaloTag(®)-odorant receptor library with allyl phenyl acetate, revealed both known receptors as best responders for this compound. In summary, the IL-6–HaloTag(®) represents a promising tool for the de-orphaning of ORs.